MARKET

SPHRY

SPHRY

Starpharma Holdings Ltd
OTCQX
2.400
NaN%
Closed 09:30 12/05 EST
OPEN
--
PREV CLOSE
2.400
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
2.750
52 WEEK LOW
0.489
MARKET CAP
--
P/E (TTM)
-15.2478
1D
5D
1M
3M
1Y
5Y
1D
Radiopharm Theranostics Partners with Starpharma to Develop Novel Radiopharmaceutical Using DEP® Platform
Reuters · 09/30 10:05
Starpharma Holdings Limited Announces Collaboration and License Agreement with Genentech for Cancer Therapy Development
Reuters · 09/22 11:30
STARPHARMA ANNOUNCES A COLLABORATION AND LICENSE AGREEMENT WITH GENENTECH
Reuters · 09/22 11:30
Weekly Report: what happened at SPHRY last week (0908-0912)?
Weekly Report · 09/15 11:00
Weekly Report: what happened at SPHRY last week (0901-0905)?
Weekly Report · 09/08 11:02
Weekly Report: what happened at SPHRY last week (0825-0829)?
Weekly Report · 09/01 10:58
STARPHARMA FY NET INCOME AUD -10 MILLION
Reuters · 08/26 00:48
Weekly Report: what happened at SPHRY last week (0818-0822)?
Weekly Report · 08/25 11:08
More
About SPHRY
Starpharma Holdings Limited is an Australia-based biotechnology company specializing in advancing dendrimer technology. The Company's principal activities are focused on the research, development and commercialization of dendrimer technology for pharmaceutical and healthcare applications. The Company's portfolio of dendrimer-based products includes three clinical-stage dendrimer enhanced product (DEP) assets, preclinical radiopharmaceutical assets, research collaborations, and three commercially marketed over the counter (OTC) products. Its clinical-stage assets, DEP SN38, DEP cabazitaxel, and DEP docetaxel, are dendrimer-based chemotherapeutic drugs. Additionally, the Company has a preclinical pipeline of DEP radiopharmaceuticals in development. It also manufactures and sells SPL7013 (astodrimer sodium) proprietary products: VivaGel BV, Viraleze nasal spray, and VivaGel condom. The Company has applied its DEP technology to the innovative area of antibody-drug conjugates.

Webull offers Starpharma Holdings Ltd stock information, including OTCQX: SPHRY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SPHRY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SPHRY stock methods without spending real money on the virtual paper trading platform.